These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17456464)

  • 1. Adherence among women with HIV infection in Puerto Rico: the potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women.
    Ciambrone D; Loewenthal HG; Bazerman LB; Zorilla C; Urbina B; Mitty JA
    Women Health; 2006; 44(4):61-77. PubMed ID: 17456464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence.
    Bradley-Ewing A; Thomson D; Pinkston M; Goggin KJ
    AIDS Patient Care STDS; 2008 Aug; 22(8):663-8. PubMed ID: 18627279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
    Macalino GE; Hogan JW; Mitty JA; Bazerman LB; Delong AK; Loewenthal H; Caliendo AM; Flanigan TP
    AIDS; 2007 Jul; 21(11):1473-7. PubMed ID: 17589194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation.
    Pearson CR; Micek M; Simoni JM; Matediana E; Martin DP; Gloyd S
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1(Suppl 1):S134-41. PubMed ID: 17133197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the impact of modified directly observed antiretroviral therapy on HIV suppression and resistance, disease progression, and death.
    Kagay CR; Porco TC; Liechty CA; Charlebois E; Clark R; Guzman D; Moss AR; Bangsberg DR
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S414-20. PubMed ID: 15156432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feasibility of modified directly observed therapy for HIV-seropositive African American substance users.
    Ma M; Brown BR; Coleman M; Kibler JL; Loewenthal H; Mitty JA
    AIDS Patient Care STDS; 2008 Feb; 22(2):139-46. PubMed ID: 18260805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa.
    Adeniyi OV; Ajayi AI; Ter Goon D; Owolabi EO; Eboh A; Lambert J
    BMC Infect Dis; 2018 Apr; 18(1):175. PubMed ID: 29653510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women.
    Turner BJ; Newschaffer CJ; Zhang D; Cosler L; Hauck WW
    Med Care; 2000 Sep; 38(9):911-25. PubMed ID: 10982113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women.
    Mellins CA; Chu C; Malee K; Allison S; Smith R; Harris L; Higgins A; Zorrilla C; Landesman S; Serchuck L; Larussa P
    AIDS Care; 2008 Sep; 20(8):958-68. PubMed ID: 18608073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified directly observed therapy for antiretroviral therapy: a primer from the field.
    Goggin K; Liston RJ; Mitty JA
    Public Health Rep; 2007; 122(4):472-81. PubMed ID: 17639650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women.
    Hodgson I; Plummer ML; Konopka SN; Colvin CJ; Jonas E; Albertini J; Amzel A; Fogg KP
    PLoS One; 2014; 9(11):e111421. PubMed ID: 25372479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of community-based modified directly observed therapy for the treatment of HIV-infected persons.
    Mitty JA; Macalino GE; Bazerman LB; Loewenthal HG; Hogan JW; MacLeod CJ; Flanigan TP
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):545-50. PubMed ID: 16044005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis.
    Laine C; Newschaffer CJ; Zhang D; Cosler L; Hauck WW; Turner BJ
    Obstet Gynecol; 2000 Feb; 95(2):167-73. PubMed ID: 10674574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lived Experience of Antiretroviral Therapy for Pregnant Women: Antiretroviral Therapy Adherence as a Balancing Act.
    Shore JE; Paun O; Vonderheid SC
    J Assoc Nurses AIDS Care; 2020; 31(4):448-456. PubMed ID: 31094866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified directly observed therapy (MDOT) for injection drug users with HIV disease.
    McCance-Katz EF; Gourevitch MN; Arnsten J; Sarlo J; Rainey P; Jatlow P
    Am J Addict; 2002; 11(4):271-8. PubMed ID: 12584870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.